Essilor: Procedures for Requesting or Viewing Proxy Information for the Combined (Ordinary & Extraordinary) Annual Meeting on...
26 March 2015 - 6:50AM
Business Wire
2015 Shareholders’ Meeting
Regulatory News:
Essilor (Paris:EI):
Shareholders are advised that the Combined (Ordinary and
Extraordinary) Annual Meeting will be held on Tuesday, May 5,
2015 at 10:30 a.m. CEST at the Palais des Congrès de Paris, 2
place de la Porte Maillot, 75017 Paris, France.
The preliminary notice of meeting, published in the Bulletin des
Annonces Légales Obligatoires on March 23, 2015, contains
information on the agenda, the proposed resolutions and the
procedures for attending and voting.
Proxy information may be viewed in the Investors section of the
Essilor corporate website at www.essilor.com: “Individual
Shareholder Information / Annual Shareholders’ Meetings”.
As provided for in Articles R.225-88 and R.225-89 of the French
Commercial Code, any shareholder may consult the proxy documents
and information, as described in Article R.225-83 of the French
Commercial Code, at Company headquarters (147 rue de Paris, 94220
Charenton-le-Pont, France) or request that such documents be sent
to him or her, by writing to:Société Générale, Service des
Assemblées, 32 rue du Champ-de-Tir, CS 30812, 44308 Nantes Cedex
03, France.
About Essilor
The world's leading ophthalmic optics company, Essilor designs,
manufactures and markets a wide range of lenses to improve and
protect eyesight. Its mission is to improve lives by improving
sight. To fulfill it, Essilor allocates more than €150 million to
research and innovation every year, in a commitment to continuously
bringing new, more effective products to market. Its flagship
brands are Varilux®, Crizal®, Transitions®, Definity®, Xperio®,
Optifog™, Foster Grant®, Bolon® and Costa®. It also develops
and markets equipment, instruments and services for eyecare
professionals.
Essilor reported consolidated revenue of nearly €5.7 billion in
2014 and employs 58,000 people. It markets its products in more
than 100 countries and has 33 plants, 490 prescription laboratories
and edging facilities, as well as several research and development
centers around the world. For more information, please visit
www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and
is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA;
Bloomberg: EI:FP.
Investor Relations and Financial CommunicationsEssilor+33
(0)1 49 77 42 16
Eurogas (CSE:EI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Eurogas (CSE:EI)
Historical Stock Chart
From Dec 2023 to Dec 2024